MAKERS LABORATORIES LTD. (MAKERSL) financials
MAKERS LABORATORIES LTD. (MAKERSL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharmaformulations.[1]
- Market Cap: ₹107Cr.
- Current Price: ₹181
- ROE: -3.13%
- ROCE: -2.57%
- Book Value: ₹92.2
- Dividend Yield: 0.00%
- 52W High / Low: ₹237/109
In Jun 2026, MAKERS LABORATORIES LTD. (MAKERSL) reported sales ₹10.19 Cr and net profit ₹-1.08 Cr.
Annual TTM: sales ₹46.80 Cr, net profit ₹-2.52 Cr.
Shareholding: Promoters 61.28% (Jun 2026), DIIs 0.39% (Jun 2026), Public 38.34% (Jun 2026), No. of Shareholders 3,745% (Jun 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 11.50 | 9.45 | 9.70 | 13.73 | 12.64 | 12.70 | 11.27 | 10.19 |
| Expenses | 11.66 | 10.01 | 10.92 | 13.27 | 12.72 | 11.98 | 11.64 | 10.68 |
| Operating Profit | -0.16 | -0.56 | -1.22 | 0.46 | -0.08 | 0.72 | -0.37 | -0.49 |
| OPM % | -1.39% | -5.93% | -12.58% | 3.35% | -0.63% | 5.67% | -3.28% | -4.81% |
| Other Income | 10.19 | 0.57 | 0.03 | 0.04 | 0.53 | 0.00 | 0.02 | 0.07 |
| Interest | 0.33 | 0.13 | 0.09 | 0.10 | 0.15 | 0.15 | 0.12 | 0.14 |
| Depreciation | 0.71 | 0.73 | 0.69 | 0.70 | 0.71 | 0.71 | 0.69 | 0.69 |
| Profit before tax | 8.99 | -0.85 | -1.97 | -0.30 | -0.41 | -0.14 | -1.16 | -1.25 |
| Tax % | 10.57% | -9.41% | -28.93% | -10.00% | -24.39% | 21.43% | -17.24% | -14.40% |
| Net Profit | 8.03 | -0.77 | -1.40 | -0.27 | -0.31 | -0.17 | -0.96 | -1.08 |
| EPS in Rs | 13.61 | -1.30 | -2.37 | -0.46 | -0.53 | -0.29 | -1.63 | -1.83 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 51.31 | 44.34 | 52.34 | 42.46 | 48.85 | 42.87 | 50.30 | 46.80 |
| Expenses | 48.55 | 41.03 | 49.24 | 46.60 | 52.60 | 45.07 | 49.57 | 47.02 |
| Operating Profit | 2.76 | 3.31 | 3.10 | -4.14 | -3.75 | -2.20 | 0.73 | -0.22 |
| OPM % | 5.38% | 7.47% | 5.92% | -9.75% | -7.68% | -5.13% | 1.45% | -0.47% |
| Other Income | 0.18 | 0.41 | 0.80 | 1.14 | 1.14 | 10.92 | 0.59 | 0.62 |
| Interest | 0.70 | 1.60 | 1.68 | 1.38 | 1.63 | 0.94 | 0.53 | 0.56 |
| Depreciation | 1.99 | 4.20 | 1.91 | 2.40 | 2.71 | 2.85 | 2.80 | 2.80 |
| Profit before tax | 0.25 | -2.08 | 0.31 | -6.78 | -6.95 | 4.93 | -2.01 | -2.96 |
| Tax % | 148.00% | -22.12% | 45.16% | -6.05% | 0.00% | 5.88% | -14.43% | — |
| Net Profit | -0.12 | -1.62 | 0.17 | -6.36 | -6.95 | 4.64 | -1.72 | -2.52 |
| EPS in Rs | -0.20 | -2.75 | 0.29 | -10.78 | -11.78 | 7.86 | -2.92 | -4.28 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.92 | 4.92 | 4.92 | 4.92 | 5.90 | 5.90 | 5.90 | 5.90 |
| Reserves | 36.78 | 39.70 | 44.70 | 45.38 | 52.38 | 45.55 | 50.18 | 48.53 |
| Borrowings | 6.38 | 13.05 | 15.99 | 19.40 | 11.20 | 15.37 | 1.76 | 3.88 |
| Other Liabilities | 11.94 | 16.20 | 13.51 | 15.78 | 15.30 | 19.33 | 13.55 | 15.23 |
| Total Liabilities | 60.02 | 73.87 | 79.12 | 85.48 | 84.78 | 86.15 | 71.39 | 73.54 |
| Fixed Assets | 18.10 | 32.89 | 30.59 | 29.94 | 40.45 | 39.88 | 29.38 | 26.92 |
| CWIP | 6.42 | 0.69 | 0.12 | 8.94 | 0.04 | 0.00 | 0.04 | 0.06 |
| Investments | 11.16 | 15.04 | 23.66 | 22.55 | 22.52 | 22.56 | 22.59 | 22.60 |
| Other Assets | 24.34 | 25.25 | 24.75 | 24.05 | 21.77 | 23.71 | 19.38 | 23.96 |
| Total Assets | 60.02 | 73.87 | 79.12 | 85.48 | 84.78 | 86.15 | 71.39 | 73.54 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 5.39 | 4.23 | 0.67 | 6.80 | -1.42 | -3.06 | -1.59 | -2.02 |
| Cash from Investing Activity | -8.31 | -8.43 | -2.65 | -8.78 | -3.55 | -2.04 | 16.14 | 0.28 |
| Cash from Financing Activity | 3.92 | 2.91 | 1.37 | 1.77 | 4.94 | 5.12 | -14.56 | 1.75 |
| Net Cash Flow | 1.00 | -1.29 | -0.61 | -0.21 | -0.04 | 0.02 | -0.01 | 0.00 |
| Free Cash Flow | -3.50 | -4.35 | -0.76 | -4.21 | -5.55 | -5.69 | 14.49 | -2.32 |
| CFO/OP | 283% | 155% | 62% | 237% | 25% | 73% | 52% | -195% |
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% |
| DIIs | 0.00% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% |
| Public | 38.73% | 38.33% | 38.34% | 38.35% | 38.35% | 38.35% | 38.34% | 38.34% |
| No. of Shareholders | 4,008 | 4,031 | 4,135 | 4,073 | 4,026 | 3,926 | 3,801 | 3,745 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 39.32 | 53.71 | 59.19 | 37.31 | 64.73 | 49.09 | 48.28 | 43.32 |
| Inventory Days | 147.65 | 132.22 | 176.97 | 159.36 | 109.67 | 135.03 | 122.14 | 149.25 |
| Days Payable | 49.81 | 90.79 | 98.48 | 52.16 | 61.39 | 101.09 | 98.05 | 106.05 |
| Cash Conversion Cycle | 137.16 | 95.14 | 137.68 | 144.51 | 113.01 | 83.03 | 72.36 | 86.53 |
| Working Capital Days | 72.45 | 24.47 | 14.74 | -59.28 | -15.73 | -36.99 | 21.71 | 16.33 |
| ROCE % | 7.63% | 1.80% | -1.05% | 3.02% | -7.77% | -7.84% | -6.79% | -2.57% |
Makers Laboratories Ltd.
₹107Cr.
₹181
₹237/109
Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharmaformulations.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of MAKERS LABORATORIES LTD. (MAKERSL)?
The reported market capitalisation for MAKERS LABORATORIES LTD. (MAKERSL) is ₹107Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of MAKERSL?
The current price shown for MAKERS LABORATORIES LTD. (MAKERSL) on Fincrux is ₹181 with a 52-week high/low of ₹237/109.
What were MAKERSL latest quarterly results?
For Jun 2026, MAKERS LABORATORIES LTD. (MAKERSL) reported sales ₹10.19 Cr and net profit ₹-1.08 Cr (figures in ₹ crore unless noted).
What are MAKERSL annual sales and net profit?
For TTM, MAKERS LABORATORIES LTD. (MAKERSL) shows sales of ₹46.80 Cr and net profit of ₹-2.52 Cr on the Fincrux profit & loss statement.
Who owns MAKERS LABORATORIES LTD. (MAKERSL)?
Latest shareholding for MAKERS LABORATORIES LTD. (MAKERSL) on Fincrux: Promoters 61.28% (Jun 2026), DIIs 0.39% (Jun 2026), Public 38.34% (Jun 2026), No. of Shareholders 3,745% (Jun 2026).
Where can I find MAKERS LABORATORIES LTD. (MAKERSL) financials?
MAKERS LABORATORIES LTD. (MAKERSL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show MAKERSL balance sheet and cash flow?
Yes. The MAKERS LABORATORIES LTD. (MAKERSL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.